# Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

> **NCT02458651** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1378 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer, Lung Cancer, Cancer

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02458651
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-26
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-10-30
- **Target enrollment:** 1378 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458651, "Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02458651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*